AssetMark’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
AssetMark's RMD Position: Q3 2026 in Review
AssetMark reduced its ResMed (RMD) stake by 6.8% in Q3 2026, selling an estimated $50.4K and leaving 3,170 shares worth $701K. The position accounts for ﹤0.01% of the portfolio, ranked #1170.
AssetMark first reported a position in RMD in Q4 2015 and has held it in 22 quarters since. The position peaked at $723K in Q1 2026. 741 funds tracked by Wall St. Rank hold RMD as of Q3 2026.
- AssetMark held 3,170 shares of ResMed worth $701K as of Q3 2026.
- AssetMark sold 231 ResMed shares in Q3 2026, an estimated $50.4K.
- ResMed made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #1170 holding.
- AssetMark first reported a position in ResMed in Q4 2015 and has held it in 22 quarters since.
- AssetMark's ResMed position peaked at $723K in Q1 2026.
- 741 funds tracked by Wall St. Rank held ResMed as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.